Back
Garmin Vs. Akero Therapeutics Industry Stock Comparison
Buy
59
GRMN
Garmin
Last Price:
$203.72
Seasonality Move:
6.83%
Sell
37
AKRO
Akero Therapeutics
Last Price:
$47.52
Seasonality Move:
19.25%
Sell
37
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $38.14. The Score for AKRO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $38.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
GRMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.16 | Buy |
Relative Strength Index (14 RSI): | 59.08 | Buy |
Chaikin Money Flow: | 329326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (188.43 - 200.59) | Buy |
Bollinger Bands (100): | (195.08 - 220.64) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 42.37 | Sell |
Chaikin Money Flow: | -238039 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.12 - 43.32) | Sell |
Bollinger Bands (100): | (31.21 - 49.45) | Sell |
GRMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 199.12 | Buy |
20-day SMA: | 195.6 | Buy |
50-day SMA: | 200.04 | Buy |
200-day SMA: | 196.83 | Buy |
8-day EMA: | 200.17 | Buy |
20-day EMA: | 197.13 | Buy |
50-day EMA: | 199.94 | Buy |
200-day EMA: | 193.7 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.83 | Sell |
20-day SMA: | 41.47 | Sell |
50-day SMA: | 41.14 | Sell |
200-day SMA: | 34.49 | Buy |
8-day EMA: | 39.76 | Sell |
20-day EMA: | 40.58 | Sell |
50-day EMA: | 40.95 | Sell |
200-day EMA: | 36.11 | Buy |
Garmin Earnings Growth & GRMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.06 per share, an increase this year of $0.96 per share, and an increase next year of $0.67 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.70 per share.
Garmin Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |